🇺🇸 FDA
Pipeline program

SGLT2 inhibitor

WestChinaH-Metformin

Unknown small_molecule completed

Quick answer

SGLT2 inhibitor for Kidney Transplantation is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Kidney Transplantation
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials